Articles tagged with: lamivudine

CATIE joins in mourning the death of a brilliant scientist and friend – Professor Dr. Mark Wainberg

published: April, 14, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Activism, Social Media, As Prevention , CATIE, Current Affairs, General Health, Treatment Guidelines -including when to start, CATIE - HIV and Hep C Info Resource, Health, Treatment, Media

Those of us in Canada and around the globe who struggle to end the HIV epidemic have lost a friend, mentor and key ally.

CATIE joins in mourning the death of a brilliant scientist and friend – Professor Dr. Mark Wainberg

Dr. Mark Wainberg passed away suddenly earlier this week. He was a brilliant scientist who helped to greatly extend our understanding about HIV and how this virus can develop resistance to treatment.  Dr. Wainberg’s career was centred at McGill University where he was the Director of the McGill AIDS Centre.  He became internationally renowned for the impact that his laboratory had on HIV treatment, as well as for the global impact of his efforts to help make HIV treatment more accessible.

HIV drug costs: potential for 90% reduction in costs coming soon?

published: November, 11, 2016 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Conferences, Treatment Guidelines -including when to start, Health, International , Revolving Door, Treatment, Guest Authors

Insurers in the United States are liable to pay up to four times the price paid by the UK’s NHS for branded antiretrovirals. From AIDSmap.com, Keith Alcorn of thebody.com on the need for more pricing transparency.

HIV drug costs: potential for 90% reduction in costs coming soon?

This article by Keith Alcorn previously appeared at AIDSmap.com, here. The costs of making drugs to treat viral hepatitis, HIV and tuberculosis (TB) are now so low that each disease could be treated for less than $90, Dr Andrew Hill of St Stephen’s AIDS Trust told the opening plenary of the International Congress on Drug Therapy in HIV Infection (HIV Glasgow) on Sunday in Glasgow. The cost of generic drugs to cure TB is already below $90 for a six-month treatment course, and some anti

Two-drug HIV therapy just as effective as three-drug therapy

published: November, 09, 2016 Written by // Guest Authors - Revolving Door Categories // Social Media, Conferences, Health, Revolving Door, International , Treatment, Guest Authors

For AIDSmap, Keith Alcorn reports from the International Congress on Drug Therapy in HIV Infection (HIV Glasgow).

Two-drug HIV therapy just as effective as three-drug therapy

This article by Keith Alcorn previously appeared at AIDSmap.com, here. Simplification of an antiretroviral treatment to a boosted protease inhibitor and the nucleoside analogue lamivudine (a dual regimen) is highly effective in people switching from a stable three-drug regimen, researchers reported on Monday at the International Congress on Drug Therapy in HIV Infection (HIV Glasgow). Boosted protease inhibitors combined with lamivudine have the potential to really reduce the cost of long-t